StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
HCAT

Health Catalyst, Inc.

HCAT Nasdaq Services-Computer Programming, Data Processing, Etc. EDGAR ↗
$2.28
+0.07 +3.17%

Key statistics

from XBRL data in SEC filings
Market cap
$168M
Revenue (TTM)
$302M
Net income (TTM)
-$265M
EPS (TTM)
$-3.73
P/E ratio
Dividend yield
Free cash flow
-$237K
Cash
$59.9M
Total assets
$412M
Gross margin
52-week range
$0.96 – $3.88

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jul 20, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Director or officer change; Regulation FD disclosure Apr 30, 2026 8-K Director or officer change; Other events Apr 27, 2026 8-K Director or officer change Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Director or officer change; Regulation FD disclosure Feb 18, 2026 8-K Director or officer change Jan 23, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Director or officer change; Regulation FD disclosure Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release); Director or officer change Aug 7, 2025 8-K Shareholder vote results Jul 10, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release); Director or officer change Feb 26, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Unregistered sale of equity; Director or officer change; Other events Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jul 18, 2024 8-K Shareholder vote results Jun 17, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 23, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release); Director or officer change Feb 22, 2024 8-K Other events Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Results of operations (earnings release) Nov 2, 2023